Skip to main content
Funded Studies

Armin Giese, Prof. Dr. med., MD

Chief Scientific Officer at MODAG GmbH

Location: Wendelsheim Germany

Dr. Giese is the CSO of the German biotech company, MODAG. Prior to this role, he was Acting Head of Department at the Center for Neuropathology and Prion Research (ZNP) at the University of Munich and Acting Head of the German Reference Center for Neurodegenerative Diseases (DGNN). He holds a Bachelor of Science from the University College London, Medical Licenses from the University of Kiel and a Doctor of Medicine from the University of Göttingen.

Dr. Giese is a board-certified neuropathologist, and he has published more than 180 highly cited scientific papers. His research focuses on the role of protein aggregation in neurodegenerative diseases. Dr. Giese developed new methods for detecting protein aggregates and screening for compounds that disrupt this accumulation. Using this technology, he identified novel aggregation inhibitors that display excellent medical properties and high efficacy in cells. Based on these findings, he co-founded MODAG in 2013. 


Associated Grants

  • Development of Selective Markers for Imaging Abnormal Protein Aggregates in Parkinson’s Disease

    2021


  • Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients

    2020


  • Pre-clinical Development of the Oligomer Modulator anle138b and Establishment of a Novel Seeding-based Biomarker

    2015


  • Evaluation of the Oligomer Modulator anle138b in a Seeding-based Model of Parkinson’s Disease

    2014


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.